# Clinical Note (De-identified)
## HPI
Patient with metastatic melanoma, BRAF V600E positive by prior testing. ECOG 1.

## Assessment and Plan
Initiate targeted therapy per guidelines. Monitor toxicity and response. Consider immunotherapy sequencing.

## Pathology
Melanoma, confirmed. Molecular: BRAF p.Val600Glu (V600E) detected.
